Since all neoantigen-specific T cell clones in this study were isolated from healthy individuals, it remains unclear whether DNMT3A-R882H neoantigen-specific CD4 T cells are circulating in patients with AML. This evidence concerns the gene DNMT3A and acute myeloid leukemia.